- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Prostate Adenocarcinoma in Poland
Total 1131 results
-
Astellas Pharma IncAstellas Pharma US, Inc.TerminatedProstatic Neoplasms | Hormone-Refractory Prostate CancerUnited States, Ireland, Australia, France, United Kingdom, Belgium, Germany, Netherlands, Poland, Spain
-
Movember FoundationKing's College London; Centre hospitalier de l'Université de Montréal (CHUM); University of California, San Francisco and other collaboratorsActive, not recruitingINTense ExeRcise for surviVAL Among Men With Metastatic Prostate Cancer (INTERVAL - GAP4) (INTERVAL)Metastatic Prostate CancerUnited States, Australia, Netherlands, Canada, United Kingdom, Germany, Ireland
-
The Netherlands Cancer InstituteRecruiting
-
Threshold PharmaceuticalsPRA Health SciencesTerminatedBenign Prostatic Hyperplasia | Enlarged ProstateHungary, Poland, Germany, Italy
-
Spanish Oncology Genito-Urinary GroupApices Soluciones S.L.; Janssen, LPCompleted
-
Tavanta TherapeuticsCompletedMetastatic Prostate Cancer | Metastatic Castration-sensitive Prostate Cancer | Metastatic Castration-resistant Prostate CancerUnited States, Spain, United Kingdom, Hungary, France, Poland, Puerto Rico, Sweden
-
Andrew J. Armstrong, MDNovartis PharmaceuticalsTerminatedProstate Cancer | Metastatic (Spread to Other Areas of the Body)United States
-
PRAECIS Pharmaceuticals Inc.CompletedProstate CancerUnited States
-
European Organisation for Research and Treatment...CompletedProstate CancerBelgium, Poland, Italy, Austria, France, Denmark, Netherlands, United Kingdom, Israel, Spain, Portugal
-
Harpoon TherapeuticsTerminatedAdvanced Prostate CancerUnited States, United Kingdom
-
US Oncology ResearchPfizerCompleted
-
DendreonCompletedProstatic Neoplasms | Advanced Prostate CancerUnited States
-
NYU Langone HealthNovartisCompletedProstatic Neoplasms | Prostate CancerUnited States
-
Novartis PharmaceuticalsCompletedMetastatic Hormone Refractory Prostate CancerUnited States, France, Spain, Belgium, Singapore, Italy, Australia, Germany
-
DendreonCompletedProstate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterBristol-Myers Squibb; Northwestern University; Oregon Health and Science UniversityActive, not recruiting
-
Medi-Tate Ltd.CompletedBenign Prostate HyperplasiaUnited States, Canada
-
GlaxoSmithKlineCompletedNeoplasms, ProstateUnited States, Australia, France, Germany, Spain, Bulgaria, Estonia, Italy, Poland, Netherlands, Belgium, United Kingdom, Canada, Denmark, Ukraine, Finland, Latvia, Russian Federation, Greece, Slovenia, Brazil, Mexico, Slovakia, Japan, Puerto... and more
-
VA Office of Research and DevelopmentRecruitingMetastatic Prostate CancerUnited States
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedCastration-Resistant Prostate CancerUnited States, Canada, France, Spain, United Kingdom, Australia, Poland, Germany, Austria, Belgium, Netherlands, Italy, Chile, South Africa, Argentina
-
Molecular Insight Pharmaceuticals, Inc.CompletedProstate CancerUnited States, Belgium, Italy, Czech Republic, Hungary, Netherlands, Poland, Russian Federation
-
NRG OncologyNational Cancer Institute (NCI)Recruiting
-
Ionis Pharmaceuticals, Inc.CompletedCastrate-Resistant Prostate CancerUnited States, Puerto Rico, Hungary, Romania, Russian Federation, Poland
-
Novartis PharmaceuticalsCompletedProstate CancerCanada, United States
-
Arvinas Androgen Receptor, Inc.Active, not recruitingProstate Cancer MetastaticUnited States
-
IpsenTerminatedProstate CancerUnited Kingdom, Spain, France, Belgium, Poland, Latvia, Lithuania, Ukraine
-
OHSU Knight Cancer InstituteOregon Health and Science University; Blue Earth DiagnosticsRecruitingProstate CancerUnited States
-
Jagiellonian UniversityUnknown
-
Medical University of LublinUnknownAdenocarcinoma of the Gastroesophageal JunctionPoland
-
University of Colorado, DenverBoston Scientific CorporationTerminated
-
AstraZenecaCompletedNon-Metastatic Prostate CancerCzech Republic, Italy, South Africa, United Kingdom, Germany, Poland, Netherlands, Austria, Belgium, Hungary, Israel, Portugal, Mexico, Spain, Australia, Ireland
-
NRG OncologyNational Cancer Institute (NCI)Active, not recruitingStage II Prostate AdenocarcinomaUnited States, Canada, Hong Kong, Switzerland, India, Ireland
-
AstraZenecaCompletedNon-metastatic Prostate CancerUnited States, Canada
-
AstraZenecaNot yet recruitingHepatocellular Carcinoma | Prostate CancerUnited States
-
AmgenUnknownPain | Prostate CancerUnited States
-
Arvinas Androgen Receptor, Inc.Active, not recruitingProstate Cancer MetastaticCanada, United States, France, United Kingdom
-
DendreonPRA Health SciencesActive, not recruitingAdenocarcinoma of the ProstateUnited States
-
Bavarian NordicCompletedProstate Cancer MetastaticUnited States, Spain, Germany, Netherlands, Belgium, United Kingdom, Australia, Denmark, France, Canada, Israel, Russian Federation, Puerto Rico, Estonia, Poland, Iceland
-
Bristol-Myers SquibbCompleted
-
European Organisation for Research and Treatment...CompletedProstate Cancer | Metastatic CancerNetherlands, Denmark, Belgium, Poland, Switzerland, United Kingdom, Italy, Russian Federation, Portugal
-
Bristol-Myers SquibbTerminated
-
AgennixCompletedProstate Cancer | Hormone Refractory Prostate CancerUnited States, United Kingdom, France, Italy, Israel, Germany, Hungary, Argentina, Russian Federation, Belgium, Croatia, Netherlands, Peru, Poland, Spain
-
Brown UniversityThe Miriam HospitalCompletedProstate CancerUnited States
-
Swiss Group for Clinical Cancer ResearchTerminatedProstate Cancer | Prostate Cancer MetastaticFrance, Switzerland, Spain, Italy
-
CureVacTerminatedTrial of RNActive®-Derived Prostate Cancer Vaccine in Metastatic Castrate-refractory Prostate CancerProstate CancerFrance, Czech Republic, Germany, Poland, Spain, Sweden, Switzerland, United Kingdom
-
AstraZenecaMerck Sharp & Dohme LLCCompletedMetastatic Castration-resistant Prostate CancerBelgium, France, Italy, Netherlands, Poland, United States, Canada, Czechia, Russian Federation, United Kingdom, Spain
-
NRG OncologyNational Cancer Institute (NCI)Active, not recruitingCancer Survivor | Prostate AdenocarcinomaUnited States
-
Aragon Pharmaceuticals, Inc.Completed
-
University of Michigan Rogel Cancer CenterMerck Sharp & Dohme LLC; Hoosier Cancer Research NetworkRecruitingNeuroendocrine Tumors | Prostate Cancer MetastaticUnited States
-
Novartis PharmaceuticalsCompletedProstate CancerUnited States